BRPI0800612A2 - método e kit para a quantificação de subclasses de igg humanas especìficas a alérgenos para o acompanhamento da imunoterapia especìfica - Google Patents

método e kit para a quantificação de subclasses de igg humanas especìficas a alérgenos para o acompanhamento da imunoterapia especìfica

Info

Publication number
BRPI0800612A2
BRPI0800612A2 BRPI0800612-1A BRPI0800612A BRPI0800612A2 BR PI0800612 A2 BRPI0800612 A2 BR PI0800612A2 BR PI0800612 A BRPI0800612 A BR PI0800612A BR PI0800612 A2 BRPI0800612 A2 BR PI0800612A2
Authority
BR
Brazil
Prior art keywords
specific
allergen
kit
antibodies
der
Prior art date
Application number
BRPI0800612-1A
Other languages
English (en)
Inventor
Ernesto Akio Taketomi
Oliveira Silva Deise Aparecida De
Original Assignee
Fundacao Fapemig
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacao Fapemig filed Critical Fundacao Fapemig
Priority to BRPI0800612-1A priority Critical patent/BRPI0800612A2/pt
Priority to PCT/BR2008/000124 priority patent/WO2009082798A1/en
Priority to EP08733527.9A priority patent/EP2232265B1/en
Publication of BRPI0800612A2 publication Critical patent/BRPI0800612A2/pt
Priority to US12/830,240 priority patent/US20110008806A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

MéTODO E KIT PARA A QUANTIFICAçãO DE SUBCLASSES DE IgG HUMANAS ESPECìFICAS A ALéRGENOS PARA O ACOMPANHAMENTO DA IMUNOTERAPIA ESPECìFICA. A presente invenção tem como objetivo fornecer um método para quantificar níveis de subclasses de anticorpos IgG humanos, particularmente das subclasses IgGl, IgG2, IgG3 ou IgG4, específicos a alérgenos através de uma técnica imunoenzimática ELISA reversa, e um kit compreendendo placas de microtitulação para ELISA já sensibilizadas/revestidas com anticorpos monoclonais, por exemplo, anti-Der p 1 ou anti-Der p 2, extrato total de alérgenos correspondentes, anticorpos secundários marcados, conjugado enzimático, substrato enzimático e tampão cromógeno, além dos soros controles positivo e negativo de referência, proporcionando, assim, maior sensibilidade na detecção dos anticorpos específicos das subclasses de IgG, como uma potencial ferramenta para o acompanhamento da imunoterapia específica com alérgenos em pacientes com doença alérgica respiratória.
BRPI0800612-1A 2008-01-02 2008-01-02 método e kit para a quantificação de subclasses de igg humanas especìficas a alérgenos para o acompanhamento da imunoterapia especìfica BRPI0800612A2 (pt)

Priority Applications (4)

Application Number Priority Date Filing Date Title
BRPI0800612-1A BRPI0800612A2 (pt) 2008-01-02 2008-01-02 método e kit para a quantificação de subclasses de igg humanas especìficas a alérgenos para o acompanhamento da imunoterapia especìfica
PCT/BR2008/000124 WO2009082798A1 (en) 2008-01-02 2008-04-29 Method and kit for quantifying of allergen-especific human igg subclasses for the control and attendance of specific immunotherapy
EP08733527.9A EP2232265B1 (en) 2008-01-02 2008-04-29 Method for quantifying allergen-especific human igg subclasses for the control and attendance of specific immunotherapy
US12/830,240 US20110008806A1 (en) 2008-01-02 2010-07-02 Method and kit for quantifying of allergen-specific human igg subclasses for the control and attendance of specific immunotherapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0800612-1A BRPI0800612A2 (pt) 2008-01-02 2008-01-02 método e kit para a quantificação de subclasses de igg humanas especìficas a alérgenos para o acompanhamento da imunoterapia especìfica

Publications (1)

Publication Number Publication Date
BRPI0800612A2 true BRPI0800612A2 (pt) 2009-08-25

Family

ID=40823716

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0800612-1A BRPI0800612A2 (pt) 2008-01-02 2008-01-02 método e kit para a quantificação de subclasses de igg humanas especìficas a alérgenos para o acompanhamento da imunoterapia especìfica

Country Status (4)

Country Link
US (1) US20110008806A1 (pt)
EP (1) EP2232265B1 (pt)
BR (1) BRPI0800612A2 (pt)
WO (1) WO2009082798A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI507689B (zh) * 2011-11-16 2015-11-11 Taichung Veterans General Hospital Vacrs Dust mite test specimen, detection kit and detection method
GB201511364D0 (en) * 2015-06-29 2015-08-12 Binding Site Group The Ltd Method of detecting or monitoring an IgG4-related disease
CN106405090A (zh) * 2015-08-14 2017-02-15 翁晖 一种用于鉴定每品种变应原制剂批间差异的方法
KR102676276B1 (ko) * 2017-01-18 2024-06-18 싸토리우스 바이오애널리티컬 인스트루먼츠, 아이엔씨 생물학적 샘플로부터 면역글로불린 감마 (IgG) 항체 아이소타입 농도를 결정하는 방법
CN108614120A (zh) * 2018-05-03 2018-10-02 辽宁汇普源生物医学科技开发有限责任公司 基于IgG4抗体捕获气传过敏原的ELISA试剂盒
CN108845122A (zh) * 2018-05-03 2018-11-20 辽宁汇普源生物医学科技开发有限责任公司 基于IgG3抗体检测气传过敏原的ELISA试剂盒
CN108646024A (zh) * 2018-05-03 2018-10-12 沈阳汇敏源生物科技有限责任公司 基于IgM抗体捕获食物过敏原的ELISA试剂盒
CN108593931A (zh) * 2018-05-03 2018-09-28 辽宁汇普源生物医学科技开发有限责任公司 基于IgA抗体捕获气传过敏原的ELISA试剂盒
CN108845124A (zh) * 2018-05-03 2018-11-20 辽宁汇普源生物医学科技开发有限责任公司 基于IgG1抗体检测气传过敏原的ELISA试剂盒
CN108593932A (zh) * 2018-05-03 2018-09-28 辽宁汇普源生物医学科技开发有限责任公司 基于IgM抗体检测气传过敏原的ELISA试剂盒
CN108646025A (zh) * 2018-05-03 2018-10-12 辽宁汇普源生物医学科技开发有限责任公司 基于IgG3抗体捕获气传过敏原的ELISA试剂盒
CN108845137A (zh) * 2018-05-03 2018-11-20 沈阳汇敏源生物科技有限责任公司 基于IgG1抗体捕获食物过敏原的ELISA试剂盒
CN108646026A (zh) * 2018-05-03 2018-10-12 沈阳汇敏源生物科技有限责任公司 基于IgG3抗体检测食物过敏原的ELISA试剂盒
CN108845136A (zh) * 2018-05-03 2018-11-20 沈阳汇敏源生物科技有限责任公司 基于IgG3抗体捕获食物过敏原的ELISA试剂盒
CN108845138A (zh) * 2018-05-03 2018-11-20 沈阳汇敏源生物科技有限责任公司 基于IgM抗体检测食物过敏原的ELISA试剂盒
CN108845123A (zh) * 2018-05-03 2018-11-20 辽宁汇普源生物医学科技开发有限责任公司 基于IgM抗体捕获气传过敏原的ELISA试剂盒
CN108445234A (zh) * 2018-05-03 2018-08-24 沈阳汇敏源生物科技有限责任公司 基于IgG4抗体捕获食物过敏原的ELISA试剂盒
CN108646023A (zh) * 2018-05-03 2018-10-12 辽宁汇普源生物医学科技开发有限责任公司 基于IgG4抗体检测气传过敏原的ELISA试剂盒
CN108593933A (zh) * 2018-05-03 2018-09-28 沈阳汇敏源生物科技有限责任公司 基于IgG1抗体检测食物过敏原的ELISA试剂盒
CN108802359A (zh) * 2018-07-06 2018-11-13 沈阳汇敏源生物科技有限责任公司 基于IgG2抗体检测食物过敏原的ELISA试剂盒
CN108872566A (zh) * 2018-07-19 2018-11-23 锦州医科大学 基于IgG2抗体检测气传过敏原的ELISA试剂盒
CN109406770B (zh) * 2018-09-30 2020-11-24 华南理工大学 一种双模式elisa酶免显色剂及其制备与应用
CN111751416A (zh) * 2020-07-03 2020-10-09 福建中医药大学 一种新型的美洲大蠊多肽快速检测方法
CN112710837B (zh) * 2020-11-03 2022-05-17 浙江大学 一种定量蒿属植物花粉中nsLTP过敏原的方法
CN116298302A (zh) * 2022-05-13 2023-06-23 杭州赛基生物科技有限公司 检测免疫球蛋白g亚类的试剂盒及其制备方法和使用方法
CN116102654A (zh) * 2022-07-08 2023-05-12 汕头大学医学院 一种双特异性抗体及其筛选方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256833A (en) * 1979-01-08 1981-03-17 Majid Ali Enzyme immunoassay for allergic disorders
JPS59208462A (ja) * 1983-04-29 1984-11-26 バイオウィッテッカー・インコーポレーテッド キモパパインの分析法
US5084379A (en) * 1983-04-29 1992-01-28 Biowhittaker, Inc. Fluorometric assay of chymopapain hypersensitivity and reagents therefor
DE3586787T2 (de) * 1984-05-11 1993-06-03 Biowhittaker Inc Fluoreszenztest fuer igg4.
FR2646917A1 (fr) * 1989-05-12 1990-11-16 Fond Nat Transfusion Sanguine Procede de dosage d'anti-corps igg anti-allergenes specifiques, fraction riche en igg4 obtenue selon ce procede et composition pharmaceutique contenant cette fraction
JPH0862217A (ja) * 1994-08-01 1996-03-08 Nippon Zeon Co Ltd 酵素免疫定量法用プレート
US6835824B1 (en) * 1995-12-29 2004-12-28 University Of Arkansas Peanut allergens and methods
US20060008895A1 (en) * 2004-07-08 2006-01-12 Hsiu-Mei Chen Microarray chip for detection of immunoglobulin
US20060160161A1 (en) * 2004-10-26 2006-07-20 Elan Pharmaceuticals, Inc. Methods for assessing antibodies to neurodegenerative disease-associated antigens

Also Published As

Publication number Publication date
US20110008806A1 (en) 2011-01-13
WO2009082798A1 (en) 2009-07-09
EP2232265B1 (en) 2016-05-18
EP2232265A4 (en) 2010-12-29
EP2232265A1 (en) 2010-09-29

Similar Documents

Publication Publication Date Title
BRPI0800612A2 (pt) método e kit para a quantificação de subclasses de igg humanas especìficas a alérgenos para o acompanhamento da imunoterapia especìfica
BRPI0919853B8 (pt) anticorpo ou fragmento de ligação ao antígeno do mesmo que se liga especificamente ao receptor de interleucina-4 humano (hil-4r) e seus usos
BR112013009376A2 (pt) métodos para determinar isótipos de anticorpos antifármacos
HRP20201840T1 (hr) Postupci za ocjenjivanje imunološkog odgovora na terapijsko sredstvo
BRPI0923199B8 (pt) método para determinar a presença de anticorpos de fixação de complemento
BRPI0719953B8 (pt) anticorpos humanos de alta afinidade para receptor de il-4 humano
BRPI0712224B8 (pt) anticorpos de alta afinidade para o receptor de il-6 humano e composições farmacêuticas
BR112013027867A2 (pt) "método de detectar o nível de um anticorpo anti-ip10 em amostra, anticorpo monoclonal isolado ou porção de ligação de antígeno do mesmo, linhagem de célula de hibridoma e kit"
MA30353B1 (fr) Anticorps se liant à la protéine tyrosine phosphatase bêta humaine (hptpbêta) et utilisations correspondantes.
BRPI0611414B8 (pt) anticorpo ou fragmento de ligação ao antígeno do mesmo que se liga ao tweak humano, composição farmacêutica e seus usos
UA104297C2 (en) Anti-il-12/il-23 antibody
EA201000245A1 (ru) Человеческие нейтрализующие антитела к фактору роста нервов (ngf) в качестве селективных ингибиторов метаболического пути ngf
BRPI0607486A2 (pt) anticorpo l243 humanizado, anticorpo biespecìfico ou fragmentos de ligação a antìgeno dos mesmos, composição farmacêutica, kit e uso dos referidos anticorpos
BR112012009846B8 (pt) método in vitro e kit para detecção de um anticorpo antifármaco de isotipo ige, e uso de um anticorpo antifármaco de isotipo ige no tratamento de distúrbio mediado por ige
BRPI0608281B8 (pt) anticorpo monoclonal humano ou seu fragmento, seu uso no tratamento de doenças inflamatórias, bem como composição farmacêutica que o compreende
EP2952896B1 (en) Method for reducing false negatives in immunoassay for assaying biomembrane-derived specimen
BR112013003262A2 (pt) anticorpos melhorados da classe igg4.
MA40041B1 (fr) Anticorps anti-gitr et leurs procédés d'utilisation
MA32577B1 (fr) Anticorps neutralisants le virus de l'influenza a et leurs utilisations
NZ701444A (en) Antibodies to matrix metalloproteinase 9
EA201190041A1 (ru) Человеческие аутоантитела против альфа-синуклеина
BRPI0716438A8 (pt) Proteínas ligantes interleucina-1,3
IL262668B2 (en) Preparations for the treatment of Gaucher disease
BR112012008665A2 (pt) tratamento de câncer
SG170051A1 (en) T cell assays

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B03H Publication of an application: rectification [chapter 3.8 patent gazette]
B06J Correction of requirement [chapter 6.10 patent gazette]

Free format text: REPUBLICACAO REFERENTE AO DESPACHO 6.6 PUBLICADO NA RPI 2155 DE 24/04/2012, REGULARIZANDO O NOME DOS DEPOSITANTES FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE MINAS GERAIS - FAPEMIG (BR/MG); ALERGOLAB - LABORATORIO DE INVESTIGACAO EM ALERGIA LTDA (BR/MG) E UNIVERSIDADE FEDERAL DE UBERLANDIA (BR/MG), ANTERIORMENTE PUBLICADO COM INCORRECAO NA RPI 2016 DE 25/08/2009 E RETIFICADO NA RPI 2189 DE 18/12/2012.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL